期刊文献+

葡萄糖酸锌合布拉氏酵母菌治疗小儿秋季腹泻50例临床观察 被引量:7

The Clinical Analysis of Zinc Gluconate Combined Brady's Yeast for the Treatment of Infantile Autumn Diarrhea
下载PDF
导出
摘要 目的:观察葡萄糖酸锌联合布拉氏酵母菌治疗小儿秋季腹泻的临床疗效。方法:选取小儿秋季腹泻病例89例,依据治疗措施不同分为对照组39例和观察组50例。对照组给予布拉氏酵母菌,观察组在对照组的基础上联合口服葡萄糖酸锌,治疗4周后观察比较两组的胃肠道症状评分及治疗总有效率。结果:观察组治疗后胃肠道症状评分明显优于对照组;观察组临床治疗总有效率(100%)明显高于对照组(79.5%),差异均有统计学意义(P<0.05)。结论:葡萄糖酸锌联合布拉氏酵母菌治疗小儿秋季腹泻临床症状改善明显,预后恢复良好,值得临床推广应用。 Objective To analyse the curative effect of Zinc gluconate combined brady's yeast for the treatment of infantile autumn diarrhea.Methods Select 89 cases children ,according to the different treatment measures,they were divided into the control group 39 cases and the observation group 50 cases.The control group given Brady's yeast,the observation group on the basis of the control grop combined oral Zinc gluconate,four weeks after treatment to observe the comparison of two groups of gastrointestinal symptoms score and tetal effectrve treatment.Resultsthe observation group of gastrointestinal symptom scores after treatment is better than the control group.The observation group.is significantly higher than the control group total effective rate and the differences were statisti-cally significant (P 〈0.05).Conclusion The Clinical symptoms of Zinc gluconate combined brady's yeast for the Treatment of infan-tile autumn diarrhea was improved obviously,it was worthy of clinic application.
作者 杨成敏
出处 《中国民族民间医药》 2015年第17期111-111,114,共2页 Chinese Journal of Ethnomedicine and Ethnopharmacy
关键词 葡萄糖酸锌 布拉氏酵母菌 秋季腹泻 Zinc Gluconate Brady's Yeast The Autumn Diarrhea
  • 相关文献

参考文献5

二级参考文献31

  • 1唐秋雨,林滨榕,吴斌,黄妙辉.小儿肺炎继发腹泻相关因素分析及微生态制剂的预防作用[J].中国实用儿科杂志,2005,20(12):732-734. 被引量:119
  • 2楚杰,王凤山,张大伟.布拉酵母菌的生物学作用及防治疾病应用研究进展[J].药物生物技术,2006,13(1):71-73. 被引量:52
  • 3盛晓阳,沈晓明.锌缺乏与儿童感染性疾病[J].中华儿科杂志,2007,45(3):164-166. 被引量:157
  • 4薛辛东.儿科学[M].北京:人民卫生出版社,2010:271.
  • 5Mayer LF.Mucosal immunity[J].Pediatrics,2003,111(6Pt 3):1595-1600.
  • 6Bartlett JG, Chang TW, Gurwith M, et al.Antibiotic-associated pseu- domembranous colitis due to toxin producing clostridia[J]. N Engl J Med, 1978,298(10) :531-534.
  • 7Barbut F, Meynard JL, Guiguet M, et al. Clostridium difficile-associ- ated diarrhoea in HIV infected patients : epidemiology and risk fac- tors[J]. J Acquir Immune Defic Syndr, 1997,16(3) : 176-181.
  • 8Mcfarland LV, Surawicz CM, Stamm WE. Risk factors for clostridi- um difficile carriage and C. difficile-associated diarrhoea in a cohort of hospitalized patients [ J ]. J Infect Dis, 1990,162 (3) : 678-684.
  • 9Wistro MJ, Norrby SR, Myhre EB, et al. Frequency of antibiotic-as-sociated diarrhoea in 2462 antibiotic-treated hospitalized patients : a prospective study[J]. J Antimicrob Chemother,2001,47( 1 ) :43-50.
  • 10Mcfarland LV. Epidemiology, risk factors and treatments for antibiot- ic-associated diarrhoea[J]. Dig Dis, 1998,16(5 ) :292-307.

共引文献2297

同被引文献41

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部